Medicine Information

Aleve, Vioxx, Celebrex, and Bextra: What You Need To Know About Arthritis Pain Medications


Recent controversy about the safety of pain medications for arthritis has left patients and health care professionals alike confused about which medications are safe to use. In fact, a recent survey by the Boston-based Rippe Lifestyle Institute indicated that many people with arthritis are suffering unnecessarily because they have stopped or reduced their use of pain relievers due to confusion about which drugs are considered safe.

The survey also showed that now, more than ever, those with arthritis need to understand the benefits and possible side effects associated with all arthritis pain medications. In order to do so, people with arthritis, their caregivers and families must be familiar with recent news about the two types of drugs most commonly used to treat arthritis pain - non-selective, non-steroidal anti-inflammatory drugs (NSAIDs), and another group of NSAIDs known as cyclooxygenase-2 (COX-2) specific inhibitors.

COX-2 specific inhibitors vs. Other NSAIDs

COX-2 specific inhibitors are the newest members of the NSAID class of medications. Available by prescription only, they became widely used in recent years to reduce joint pain and swelling. COX-2 specific inhibitors work by selectively blocking, or inhibiting, one of the two enzymes associated with inflammation. Some experts think that this selective inhibition may be one reason for some of the negative side effects currently associated with COX-2 specific inhibitors.

Non-selective NSAIDs were developed earlier than COX-2 specific inhibitors and have been widely used to relieve arthritis pain and inflammation for many years. Unlike COX-2 specific inhibitors, non-selective NSAIDs inhibit both major enzymes involved in the inflammatory process, COX-1 and COX-2. The non-selective NSAID category includes a number of different medications that are available in both prescription and over-the-counter (OTC) products.

Timeline of Events

To understand the current state of affairs, it is important to understand the sequence of events. The controversy started when a study published in the October 21, 2004, issue of the New England Journal of Medicine cited the COX-2 specific inhibitor, Vioxx as potentially causing "major adverse events," including heart attack and stroke, among patients taking the drug. As a result, Merck (the drug's manufacturer) voluntarily withdrew Vioxx from the market. However, in the months following, the safety of the other available COX-2 specific inhibitors such as Celebrex and Bextra, as well as other arthritis pain medications in the non-steroidal anti-inflammatory (NSAID) class, were also called into question.

Consequently, in February 2005, the US Food and Drug Administration (FDA) convened a special Advisory Committee, made up of members of the Arthritis and Drug Safety Advisory Committees, to review the cardiovascular safety of these arthritis pain medications.

FDA Directive: Stronger Warning Labels for Some Pain Medications

On April 7, 2005, taking into account the recommendations of the Advisory Committee, the FDA issued the following directives:

? Bextra, a COX-2 specific inhibitor manufactured by Pfizer, was withdrawn from the market.

? All prescription NSAIDs must revise their labeling to include a "black box" warning that highlights the potential increased risk for cardiovascular (CV) events as well as the potentially life threatening gastrointestinal (GI) bleeding associated with these drugs. Celebrex, the only COX-2 specific inhibitor remaining on the US market, was included in this directive.

? All OTC NSAIDs (except aspirin) will be required to revise their labeling to include more specific information about the potential for GI and CV side effects, a stronger reminder to follow label instructions, as well as a warning about potential skin reactions.

To further evaluate the potential for increased CV risk, the FDA also announced that all NSAIDs must conduct and submit to the FDA a comprehensive review and analysis of pertinent safety data from clinical trials.

? Aleve (naproxen sodium) is supported by clinical studies conducted to gain approval of naproxen as a prescription product and as OTC that do not provide any evidence of increased risk of cardiovascular events.

Treatment Options: What Should Arthritis Patients Know?

For some people who suffer from pain associated with arthritis, their symptoms can be managed with exercise, heat/cold therapy, joint protection, assistive devices, weight control, or in some severe cases, surgery. For others, medications are needed to help manage the symptoms associated with arthritis.

When taken as directed OTC medications such as Aleve provide a safe and effective way to treat mild to moderate pain of minor arthritis. If patients have questions, they should consult their health care professional about which treatment option is most appropriate.

Why It's Important to Treat Arthritis

Arthritis affects approximately 66 million Americans and is the nation's leading cause of disability. There are over 100 different types of arthritis, and they all have different symptoms that vary in severity from person to person. The most common form of arthritis, osteoarthritis, is characterized by the breakdown of cartilage that causes the bones to rub together, resulting in pain, loss of movements and stiffness. Arthritis is usually a chronic condition.

For more information on Aleve and naproxen, visit the Aleve website at www.aleve.com. For more information on arthritis pain relief, visit www.arthritis.org

Please visit http://www.aleve.com for more information.


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Forbes

Five Winners -- And One Loser -- From Medicine's Big Meeting About Blood
Forbes
Matthew Herper , Forbes Staff I cover science and medicine, and believe this is biology's century. Johnny Wolf. Kite Founder Arie Belldegrun and BlueBird CEO Nick Leschly talk gene therapy at the Forbes Healthcare Summit. For the past two days, doctors ...



STAT

Your smartphone as medicine: Digital therapy is here to stay
STAT
The FDA recently approved 1 the first prescription digital therapy, Pear's Reset app 2 and program, which is focused on substance abuse. Others 3 are likely to follow. That means your next trip to the doctor could include a prescription for a mobile ...



DesMoinesRegister.com

Tips for administering medicine to children
DesMoinesRegister.com
As infants and young children grow and gain weight rapidly in early life, a medicine's dose often increases quickly. The dose of a medicine for an infant or child may be greater just several months later, as more weight is gained. Administering the ...



Community Advocate

Metrowest practice offers Functional Medicine
Community Advocate
Hopkinton – If you're sick of feeling unwell and you're looking for a practice that won't just push more pills, you might consider looking into the 4 Better Health Functional Medicine practice in Hopkinton. The practice is owned by Dr. Patti Zub and ...



Cystic Fibrosis News Today

Ontario Researcher Awarded Grant to Develop Precision Medicine Tool for CF
Cystic Fibrosis News Today
Hirota, a respiratory researcher at St. Joseph's and an assistant professor in the department of medicine at McMaster University in Canada, will receive $280,183 over three years under the grant. “Unfortunately, currently approved drugs fail to work in ...



Pharmacists warn of medicine scarcity in Sudan
ReliefWeb
While medicine prices increase, some life-saving medicines have become scarce in Khartoum and other states. Patients and their attendants complained that medicines have become unaffordable. Some medicines prices have exceeded the price issued that the ...

and more »


RowAnalytics' Giro Initiative Brings Precision Medicine Perspective to Neurodegenerative Disorders
GenomeWeb
NEW YORK (GenomeWeb) –RowAnalytics, the Martinos Center for Biomedical Imaging, and Envision Genomics are partnering on a new initiative called Giro Health, which they describe as an open initiative in precision medicine that seeks to improve diagnosis ...



Salt Lake Tribune

Commentary: The Tribune was wrong. Medicine often involves a risk to the patient.
Salt Lake Tribune
(Courtesy of the Utah Department of Health) A health department initiative called Talk to Your Pharmacist placed stickers on bottles to prompt prescribers to talk to their pharmacist about the risk of using opioids. By Lynn Webster | For The Tribune ...



UAB News

Celebrating 25 years of psychiatric medicine at UAB
UAB News
CPM groundbreaking ceremony, 1989. Photo provided by UAB Archives.On Sept. 27, 1989, the University of Alabama at Birmingham broke ground for a new building. The Center for Psychiatric Medicine, as the edifice on Sixth Avenue South was to be called ...



CBC.ca

Why adding beds might not solve the problem of 'hallway medicine' anytime soon
CBC.ca
Beds announced at the end of October to alleviate overcrowding at some hospitals may be slow to come on stream as hiring staff takes time, but some doctors say the move also doesn't address the underlying cause. Dr. Paul Pageau, President of the ...

and more »

Google News

home | site map | Dr. Thad Thomas
© 2006